Catalent Pharma Solutions and Sanwa Kagaku Kenkyusho., Ltd. (SKK) Announce Exclusive License For OSDrC(R) Technology, Bringing New Modified Release Delivery Technology to the Rx and OTC Global Market
7/14/2011 10:14:07 AM
More...
|
Shanghai ChemPartner Co., Ltd. and Sanwa Kagaku Kenkyusho., Ltd. (SKK) Announce Strategic Alliance
4/20/2009 10:45:36 AM
More...
|
VistaGen Therapeutics, Inc. Licenses Customized Stem Cell-Based Drug Discovery Assays to Sanwa Kagaku Kenkyusho, a Japanese Pharmaceutical Company
5/22/2008 10:08:17 AM
More...
|
VistaGen Therapeutics, Inc. And Sanwa Kagaku Kenkyusho Renew Embryonic Stem Cell Drug Discovery And Development Partnership Focused On New Diabetes Treatments
11/30/2006 11:05:59 AM
More...
|
4SC AG Enters Next Phase Of Drug Discovery Collaboration With Sanwa Kagaku Kenkyusho
1/17/2006 10:29:18 AM
More...
|
Sanwa Kagaku Kenkyusho Releases SEIBULE, Miglitol Agent For Controlling Postprandical Blood Glucose
1/11/2006 1:26:05 PM
More...
|
Allergan Inc. (AGN) And Sanwa Kagaku Kenkyusho Sign Exclusive Licensing Agreement To Develop And Market POSURDEX(R) In Japan
10/19/2005 5:13:07 PM
More...
|
4SC AG And Sanwa Kagaku Kenkyusho Enter Into Multi-Year Drug Discovery Collaboration
10/19/2005 5:12:44 PM
More...
|
Sanwa Kagaku Kenkyusho And Quark Biotech, Inc. Enter Collaboration To License Dyslipidemia Therapy
10/19/2005 5:12:39 PM
More...
|
VistaGen Therapeutics, Inc. And Sanwa Kagaku Kenkyusho Announce First Embryonic Stem Cell Research Partnership Focused On New Treatments For Diabetes
10/19/2005 5:11:49 PM
More...
|
|